Hoffmann-La Roche Inc.

États‑Unis d’Amérique


 
Quantité totale PI 3 040
Quantité totale incluant filiales 3 079 (+ 39 pour les filiales)
Rang # Quantité totale PI 372
Note d'activité PI 4/5.0    2 510
Rang # Activité PI 264
Parent Roche Holding AG
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

1 523 29
0 0
1 488 0
0
 
Dernier brevet 2024 - Combination therapy of pd-1-targ...
Premier brevet 1969 - Preparation of vinyl lactones an...
Dernière marque 2022 - ROCHE IADVISE VIRTUAL ADVISORY B...
Première marque 1897 - ROCHE

Filiales

2 subsidiaries with IP (39 patents, 0 trademarks)

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2023 Invention Whole slide image search. In one embodiment, a method includes indexing a whole slide image data...
Invention Predicting actionable mutations from digital pathology images. A method includes accessing a dig...
Invention Compounds for treating spinal muscular atrophy. The present invention provides compounds of form...
Invention Antibodies binding to nkg2d. The present invention generally relates to antibodies that bind to ...
Invention Oligonucleotides for inducing paternal ube3a expression. The present invention relates to oligon...
Invention Prevention or mitigation of nk cell engaging agent-related adverse effects. The present inventio...
Invention Peptide macrocycles against acinetobacter baumannii. The present invention provides compounds of...
Invention Positive control system and method for validating positive control of container closure integrity...
Invention A multidimensional lc system for analysing antibodies.. The invention related to a multidimension...
Invention Method for separating full and empty aav particles. Herein is reported a method for separating fu...
Invention Novel phagocytosis assay combining a synthetic cell death switch and a phagocytosis reporter syst...
Invention Inspection system and method for a closed medical container. An inspection system (1.3) is operat...
Invention T cell receptor identification. The present disclosure relates to the fields of molecular biology...
Invention Double-stranded rna molecule for administration to the eye. The present invention relates to doub...
Invention Packaging member for a photosensitive drug substance. The present invention is directed to a pack...
Invention Recombinant t cell receptors. The present disclosure relates to the fields of molecular biology, ...
Invention Prediction of pharmacokinetic properties of chemical compounds. Prediction of pharmacokinetic pro...
Invention Synthetic time-series data generation and its use in survival analysis and selection of frug for ...
Invention Novel biomarkers and uses thereof. Disclosed herein are novel biomarkers for identifying patient...
Invention Dosage regimen of vicasinabin. -tert-tert-butyl-3-[(1-methyltetrazol-5- yl)methyl]triazolo[4,5-d]...
Invention Anti-cb2 antibodies and their use in a flow cytometry assay to measure cell surface cb2 expressio...
Invention Novel synthesis of phosphorodithioate oligonucleotides. The invention provides the use of a comp...
Invention Threose nucleic acid antisense oligonucleotides and methods thereof. Described are antisense olig...
Invention Novel deuterated pyrimidin-2-yl sulfonamide derivatives. The invention relates to novel compounds...
Invention Quantifying amyloid-related imaging abnormalites (aria) in alzheimer's patients. Methods for quan...
Invention Covalent fluorescent probes for cannabinoid receptor 2. The present invention provides covalent f...
Invention Container closure integrity testing method and system. A container closure integrity (CCI) testin...
Invention Segmenting and detecting amyloid-related imaging abnormalites (aria) in alzheimer's patients. Met...
Invention Process for the de-tritylation of oligonucleotides. The invention relates to a novel process for...
Invention Prevention or mitigation of adverse effects related to recombinant viral vectors. The present inv...
Invention Bicyclic tetrahydroazepine derivatives. The present invention provides new bicyclic tetrahydroaze...
Invention S) morpholin-2-yl]phenyl]-1h-pyrazole-3-carboxamide. The present invention relates to pharmaceuti...
Invention Bicyclic tetrahydrothiazepine derivatives. The present invention provides new bicyclic tetrahydro...
Invention Process for manufacturing an antibiotic macrocyclic peptide. The invention relates to a novel pro...
Invention New heterocyclic compounds. The invention provides new heterocyclic compounds having the general ...
Invention Bispecific anti-ccl2 antibodies. The present invention relates to bispecific anti-CCL2 antibodie...
Invention Antibodies binding to gprc5d. The present invention generally relates to antibodies that bind to...
Invention Attention-based multiple instance learning. Systems and methods relate to predicting disease pro...
Invention Artificial vitreous humor for the investigation of drugs and drug formulations. The invention re...
Invention Spr-based bridging assay format for determining the biological activity of multivalent, multispec...
2022 Invention Combination therapy of pd-1-targeted il-2 variant immunoconjugates and fap/4-1bb binding molecule...
P/S Online-information services, namely, providing on-line information about accessing computer netwo...
Invention Speech-analysis based automated physiological and pathological assessment. Methods of assessing ...
Invention Split antibodies which bind to cancer cells and target radionuclides to said cells. The present ...
2021 Invention Closure system and kit. A closure system is disclosed for closing a container opening. The closu...
Invention Closure system and kit. A closure system for closing a container opening is disclosed that inclu...
Invention Closure system and kit. A closure system (3) for closing an opening (25) of a container (2) comp...
Invention Ph-dependent mutant interleukin-2 polypeptides. The present invention generally relates to pH-de...
Invention New indazole derivatives. The invention provides novel compounds having the general fo...
2020 Invention Artificial transmembrane proteins for detecting intracellular or intravesicular biomolecular inte...
2019 P/S Medical and scientific research in the field of diabetes; Consultation pertaining to pharmacology...
2017 P/S laboratory instruments, namely, clinical chemistry analyzers and immunochemistry analyzers for th...
P/S a full line of in vitro diagnostic agent, namely, reagents, control solutions for calibrating and...
P/S medical diagnostic test strips for determining the level of glucose in blood for medical and clin...
P/S blood glucose monitors for medical purposes, lancet devices, lancets; insulin delivery devices an...
2008 P/S full line of pharmaceutical preparations
P/S pharmaceutical antiviral preparation
2000 P/S [ Chemical products, namely, diagnostic preparations for scientific or medical research use; cont...
1999 P/S providing information about a pharmaceutical company and its products and services via a web site...
1997 P/S pharmaceutical preparation, namely, an anticancer drug
1994 P/S pharmaceutical preparation; namely, an antiviral
1993 P/S pharmaceutical preparation, namely an immunosuppressive agent
1985 P/S COMPUTERS AND ELECTRONIC LABORATORY TESTING APPARATUS USED FOR ANALYSIS OF BIOLOGICAL FLUIDS, PHA...
1984 P/S Clinical Laboratory Services
1982 P/S Antibiotic Preparation
1977 P/S [ PROVIDING COMPUTER SCORED PSYCHIATRIC AND PSYCHOLOGICAL TESTING SERVICES; ] PROVIDING PHARMACEU...
P/S MEDICAL BOOKLETS AND PAMPHLETS
P/S PHARMACEUTICAL PREPARATIONS FOR HUMAN [AND VETERINARY] USE
P/S IN VITRO DIAGNOSTIC REAGENTS[; ULTRASONIC COUPLING MEDIUM; AND CHEMICAL PREPARATION USED IN THE C...
P/S IN VITRO DIAGNOSTIC REAGENTS [ ; ULTRASONIC COUPLING MEDIUM; AND CHEMICAL PREPARATION USED IN THE...
1949 P/S [ AGENTS USED IN ALLERGY, ANALGESICS, ANALEPTICS, ] ANTI-INFECTIVES [, ANTISPASMODICS ANESTHETIC...
1897 P/S CHEMICAL PRODUCTS FOR USE IN MEDICINE AND PHARMACY [ , DISINFECTANTS, AND PERFUMES ]